Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. Lexaria Bioscience Corp. (LXRPD) Message Board

Yes, I could read it when I found it. However, now

Message Board Public Reply | Private Reply | Keep | Replies (1)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 721
(Total Views: 275)
Posted On: 10/08/2020 9:19:50 AM
Avatar
Posted By: Ulf53
Re: Kgem #549
Yes, I could read it when I found it. However, now it seemed to be blocked as you say. I only got this for now;


WALL STREET JOURNAL



Tobacco Companies Get a Clear Smokeless Signal
Traditional cigarette sales have been resilient in the Covid-19 crisis, but investors seem prepared to reward only innovation

Staff members measure ingredients at a Swedish Match tobacco snus store in Stockholm.
PHOTO: ANNA RINGSTROM/REUTERS
By Carol Ryan
Oct. 7, 2020 7:54 am ET

The weak performance of most tobacco stocks this year suggests it will be a slog to lose their pariah status. A rally in one outlier, Swedish Match, shows why it should be worth the effort.

Shares in the Stockholm-listed business, which makes smoke-free nicotine products like Zyn oral pouches, have gained 50% this year. Its valuation premium over tobacco giants Philip Morris International, British American Tobacco and Altria in terms of forward price-earnings multiples has grown correspondingly more extreme.

Among...

TO READ THE FULL STORY
SUBSCRIBE
SIGN IN
The Wall Street Journal
Continue reading your article with
a WSJ membership
VIEW MEMBERSHIP OPTIONS
WHAT TO READ NEXT...

Independent of The Wall Street Journal newsroom

MARKETWATCH
Philip Morris shares rise after earnings and sales beat expectations.

Independent of The Wall Street Journal newsroom.



(1)
(0)




Lexaria Bioscience Corp. (LXRPD) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  


Robert




Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us